ArticleCommunications biology2018
Acquisition of resistance to carbapenem and macrolide-mediated quorum sensing inhibition by
Article in Communications biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 46 citations in OpenAlex.
- Emergence of blaBMC microbiology · 2026Article
- Global threats in local wards: Dissemination of high-risk clones resistant to last-generation cephalosporins and carbapenems in Iraqi hospitals.IJID regions · 2026Article
- Genome-wide co-occurrence patterns link mobile genetic elements, antimicrobial resistance and defense systems in Pseudomonas aeruginosa.BMC genomics · 2026Article
- Translation quality control in Pseudomonas aeruginosa: current knowledge and perspectives.FEMS microbiology reviews · 2026Review
- First Detection and Molecular Characterization ofMicroorganisms · 2023Article
- Dissemination ofMicrobiology spectrum · 2023Article
- How does Quorum Sensing of Intestinal Bacteria Affect Our Health and Mental Status?Microorganisms · 2022Review
- Prediction of Potential Drug Targets and Vaccine Candidates Against Antibiotic-ResistantInternational journal of peptide research and therapeutics · 2022Article
- Optimization and development of high-resolution melting curve analysis (HRMA) assay for detection of New Delhi metallo-β-lactamase (NDM) producingAIMS microbiology · 2022Article
- Genomic Characterization of Mutli-Drug ResistantFrontiers in cellular and infection microbiology · 2022Article
- uCARE Chem Suite and uCAREChemSuiteCLI: Tools for bacterial resistome prediction.Genes & diseases · 2021Article
- Dynamic Adaptive Response ofAntibiotics (Basel, Switzerland) · 2021Article
- Comparative genome analysis of multidrug-resistant Pseudomonas aeruginosa JNQH-PA57, a clinically isolated mucoid strain with comprehensive carbapenem resistance mechanisms.BMC microbiology · 2021Article
- CRISPR-Cas systems restrict horizontal gene transfer in Pseudomonas aeruginosa.The ISME journal · 2021Article
- Could Azithromycin Be Part ofFrontiers in microbiology · 2021Review
- Comprehensive genome data analysis establishes a triple whammy of carbapenemases, ICEs and multiple clinically relevant bacteria.Microbial genomics · 2020Article
- Characterization of Two Macrolide Resistance-Related Genes in Multidrug-ResistantPolish journal of microbiology · 2020Article
- Identification of integrative and conjugative elements in pathogenic and commensalMicrobial genomics · 2020Article
- Activity of Cinnamaldehyde on Quorum Sensing and Biofilm Susceptibility to Antibiotics inMicroorganisms · 2020Article
- Ribosome protection by ABC-F proteins-Molecular mechanism and potential drug design.Protein science : a publication of the Protein Society · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.